Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress
Featuring perspectives from Ms Courtney Arn, Ms Jamie Carroll, Dr Edward B Garon, Dr Heather McArthur and Dr Kathleen N Moore, moderated by Dr Moore, including the following topics:
- Introduction (0:00)
- Overview of Antibody-Drug Conjugates (ADCs) (2:07)
- Current and Future Role of HER2-Targeted ADCs for Breast Cancer (6:23)
- Currently Available ADCs for Gynecologic Cancer Management (26:37)
- Currently Available ADCs for Lung Cancer Management (44:07)
- Current and Future Role of TROP2-Targeted ADCs for Metastatic Breast Cancer (56:55)
- Other ADCs That May Soon Reach the Clinic for Advanced Gynecologic Cancers (1:15:07)
- Promising Investigational Strategies Employing ADCs for Lung Cancer (1:25:01)
